Winton Group LTD Marker Therapeutics, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$2.68 - $4.85 $27,620 - $49,984	-10,306 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$4.1 - $9.0 $14,132 - $31,023	-3,447 Reduced 25.06%	10,306 $53,000
Q2 2019 Jul 08, 2019	SELL	$5.15 - $7.92 $566 - $871	-110 Reduced 0.79%	13,753 $109,000
Q1 2019 May 13, 2019	BUY	$5.1 - $6.71 $70,701 - $93,020	13,863 New	13,863 $91,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.